These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23233437)

  • 1. The MM2QM tool for combining docking, molecular dynamics, molecular mechanics, and quantum mechanics.
    Nowosielski M; Hoffmann M; Kuron A; Korycka-Machala M; Dziadek J
    J Comput Chem; 2013 Apr; 34(9):750-6. PubMed ID: 23233437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
    Minovski N; Perdih A; Novic M; Solmajer T
    J Comput Chem; 2013 Apr; 34(9):790-801. PubMed ID: 23280926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of pyrazole-based inhibitors to Mycobacterium tuberculosis pantothenate synthetase: docking and MM-GB(PB)SA analysis.
    Ntie-Kang F; Kannan S; Wichapong K; Owono Owono LC; Sippl W; Megnassan E
    Mol Biosyst; 2014 Feb; 10(2):223-39. PubMed ID: 24240974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations.
    Sengupta S; Roy D; Bandyopadhyay S
    J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).
    Khan AM; Shawon J; Halim MA
    J Mol Graph Model; 2017 Oct; 77():386-398. PubMed ID: 28957755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
    ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB; Jogula S; Reddy AP; Saxena S; Sridevi JP; Sriram D; Yogeeswari P
    Mol Inform; 2015 Feb; 34(2-3):147-59. PubMed ID: 27490037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
    Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking.
    Anuradha CM; Mulakayala C; Babajan B; Naveen M; Rajasekhar C; Kumar CS
    J Mol Model; 2010 Jan; 16(1):77-85. PubMed ID: 19484275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
    Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
    SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
    Soni V; Suryadevara P; Sriram D; ; Kumar S; Nandicoori VK; Yogeeswari P
    J Mol Model; 2015 Jul; 21(7):174. PubMed ID: 26078037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
    Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
    J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative modeling and dynamic simulation of UDP-N-acetylmuramoyl-alanine ligase (MurC) from Mycobacterium tuberculosis through virtual screening and toxicity analysis.
    Isa MA
    Life Sci; 2020 Dec; 262():118466. PubMed ID: 32961233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
    Agrawal H; Kumar A; Bal NC; Siddiqi MI; Arora A
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3053-8. PubMed ID: 17418569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantum mechanics/molecular mechanics strategies for docking pose refinement: distinguishing between binders and decoys in cytochrome C peroxidase.
    Burger SK; Thompson DC; Ayers PW
    J Chem Inf Model; 2011 Jan; 51(1):93-101. PubMed ID: 21133348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.